Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Acral Melanosis with Macromelanosomes (AMM): The First AI-Defined Pathological Entity and Proposal of Provisional Diagnostic Criteria

3 months 2 weeks ago
Artificial intelligence (AI) has started to transform diagnostic workflows in pathology, yet no formal pathological entity has been named, defined, and documented in the medical literature by an AI system. We report a benign acral pigmentary process characterized by conspicuous keratinocyte macromelanosomes with otherwise normal melanocyte density and architecture. We propose the term "acral melanosis with macromelanosomes (AMM)," a name and construct first generated with the assistance of a...
Igor Shendrik

Cytotoxicity Modulated by Cyanotoxins in Neuroblastoma SH-SY5Y Cells

3 months 2 weeks ago
Aquatic prokaryotic cyanobacteria (algal blooms) produce cyanotoxins (CTs), significant pollutants in aquatic ecosystems. Direct exposure to high-concentration CTs through inhalation, skin contact, or ingestion of contaminated water can lead to hepatotoxicity and neurotoxicity. However, the effect of exposure to CTs at low concentrations remains unclear. Given that CTs can cross the blood-brain barrier via organic anion transporting polypeptides (OATPs), we investigated the effect of acute...
Suryakant Niture

Identification of Sjögren's disease-associated T cell receptor motifs through deep sequencing

3 months 2 weeks ago
CD4+ T cells predominate lymphocytic foci found in the salivary glands (SGs) of Sjögren's disease (SjD) cases. Yet little is known about T cell receptor (TCR) repertoire features that distinguish cases from healthy controls (HCs), the relationship between SG and peripheral blood (PB) repertoires of cases, and antigens recognized by pathogenic T cell clones. We performed deep sequencing of bulk-sorted CD4+CD45RA- PB T cells from SjD cases and matched HCs, and single-cell TCR sequencing of the...
Ananth Aditya Jupudi

A 33-month-old boy with bilateral corneal disease

3 months 2 weeks ago
We report the case of a previously healthy 33-month-old boy with vitamin A deficiency (VAD) who presented with bilateral eye swelling, redness, and photophobia of 1 month's duration following multiple misdiagnoses. After confirming VAD with serum vitamin A level testing, he was treated with vitamin A, and his eye complaints improved. However, he continues to have a corneal scar and is currently undergoing amblyopia treatment.
Rachel F Dolan

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management

3 months 2 weeks ago
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has emerged as a distinct demyelinating condition with unique clinical and radiographic characteristics that differentiate it from multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD). This review provides a clinically focused update tailored for ophthalmologists, emphasizing the ocular manifestations, diagnostic workup, and current treatment strategies for MOGAD....
Rachel F Dolan

Pagination

  • Previous page ‹ Previous
  • Page 11
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies